monoprost augndropar, lausn í stakskammtaíláti 50 míkróg/ml
laboratoires thea* - latanoprostum inn - augndropar, lausn í stakskammtaíláti - 50 míkróg/ml
cofact stungulyfsstofn og leysir, lausn 500 a.e.
prothya biosolutions netherlands b.v. - factor ii human; factor vii human; factor ix human; factor x human - stungulyfsstofn og leysir, lausn - 500 a.e.
dalacin stungulyf, lausn 150 mg/ml
pfizer aps - clindamycinum fosfat - stungulyf, lausn - 150 mg/ml
sendoxan stungulyfsstofn, lausn 1 g
baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 1 g
sendoxan stungulyfsstofn, lausn 500 mg
baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 500 mg
epipen stungulyf, lausn 300 míkróg
viatris aps - adrenalinum (epinephrinum inn) - stungulyf, lausn - 300 míkróg
epipen jr. stungulyf, lausn 150 míkróg
viatris aps - adrenalinum (epinephrinum inn) - stungulyf, lausn - 150 míkróg
protaminsulphat leo pharma stungulyf, lausn 10 mg/ml
leo pharma a/s* - protamini sulfas inn - stungulyf, lausn - 10 mg/ml
genta-equine stungulyf, lausn 100 mg/ml
franklin pharmaceuticals ltd. - gentamicinum súlfat - stungulyf, lausn - 100 mg/ml
latanoprost actavis augndropar, lausn 50 míkróg/ml
actavis group ptc ehf. - latanoprostum inn - augndropar, lausn - 50 míkróg/ml